Both companies target serious health challenges, but their financials and risk profiles reveal sharply different paths for ...

Shares of NovoCure (NASDAQ: NVCR) are edging higher on Thursday. The company's stock gained 0.11% as of 3:30 p.m. ET after fluctuating between gains and losses throughout the session. This muted ...

NovoCure Limited NVCR recently announced that its portable medical device, Option Pax, has received the CE (Conformité ...

Let's start with the pessimistic view. When a stock falls as much as Novocure has over the last couple of years or so, there's always an underlying reason. The main factor behind Novocure's decline is ...

Novocure (NASDAQ: NVCR) will report financial results for the second quarter 2026 on July 23, 2026, before the U.S. financial markets open.

Novocure’ s shares stumbled nearly 20% after the company disclosed it failed to meet its primary endpoints in the TRIDENT ...

BAAR, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as ...

4 analysts have expressed a variety of opinions on NovoCure (NASDAQ:NVCR) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ...

This has been a challenging time for some medical device companies. Novocure is the latest firm to make cuts during 2023’s turbulent economy. The Root, Switzerland-based company said it was cutting 13 ...

PORTSMOUTH — Novocure Inc., a global oncology company with new headquarters being built adjacent to the Worth parking lot, has received a key approval for a rooftop penthouse. Attorney John Bosen, who ...

SAN FRANCISCO--(BUSINESS WIRE)--National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from ...